Health Care Industry Shaken After UnitedHealthcare CEO Is Killed Outside NYC Hotel

The motive for the shocking murder of Brian Thompson in New York City was still unknown Wednesday afternoon.

United Healthcare CEO Brian Thompson was shot early 4 December in New York City. (Shutterstock)

UnitedHealthcare CEO Brian Thompson was shot and killed outside the New York Hilton Midtown hotel on 4 December, ahead of the annual investor day held by UnitedHealth Group, New York Police Department officials confirmed, shocking the health care world.

More from Market Access

Newest HHS Staff Cuts Could Stymie CMS Health Plan Oversight

 
• By 

A former CMS manager worries casework and other necessary functions could suffer as a result of the 300 staff cuts at the agency that are part of a massive HHS restructuring.

Power Play: US FDA Likely Losing More Than Just Staff With Restructured Health Department

 

About 3,500 full-time FDA employees are expected to be laid off as part of a restructuring of the Health and Human Services Department and experts questioned whether the cuts could be implemented without harming FDA’s core mission.

German Ordinance To Implement HTA Reg Leaves Room For Doubt

 

A German ordinance implementing the EU Health Technology Assessment Regulation offers little clarity on how far joint clinical assessment reports should be considered by national authorities.

Think Tank Suggests CMS, USTR Could Enforce Most Favored Nation, Other Drug Pricing Policies

 
• By 

A Republican think tank suggested variations of the Most Favored Nation and international reference policies in Medicare and Medicaid, as well as tariffs and other trade levers to rebalance drug pricing disparities between US countries and abroad.

More from PBMs

This Year, PBM-Directed Fury May Once Again Signify Nothing

 
• By 

Anti-PBM sentiment continues to rise, but industry observers still question whether the reforms being discussed will be effective.

US Government Keeps Lights On But Pharma Priorities For PBM Reform, Rare Diseases Nixed

 

The FDA will stay open, but its rare disease priority review voucher program will wind down after not being renewed on 20 December. PBM reform and other industry priorities also were nixed at the last minute in an effort to avoid a government shutdown.

Chink In PBM Armor? ‘Delinking’ Policy In Spending Bill But Passage Unclear

 
• By 

Delinking policy, a reform long-sought by pharma, was included in proposed must-pass government funding legislation that was teetering on collapse.